role
virus
etiolog
infecti
diseas
children
emphas
physician
take
care
children
long
actual
evid
import
virus
inde
parent
accustom
frequent
incrimin
virus
caus
ill
children
mani
year
common
practic
blame
virus
wide
varieti
ill
character
fever
alon
fever
number
symptom
nausea
vomit
diarrhea
sore
throat
rhinorrhea
cough
skin
rash
myalgia
arthralgia
malais
name
virolog
technic
becom
less
cumbersom
less
expens
avail
would
appear
physician
invok
viru
caus
numer
ill
probabl
correct
time
basi
studi
etiolog
epidemiolog
would
appear
virus
respons
perhap
mani
etiolog
diagnos
infect
children
fortun
enough
dispos
virolog
laboratori
use
epidemiolog
studi
routin
diagnost
procedur
discuss
clinic
recogniz
viral
syndrom
draw
heavili
experi
gain
studi
publish
experi
other
hope
inform
help
physician
care
children
must
function
without
extens
laboratori
support
hope
addit
emphas
diagnost
virolog
laboratori
come
age
technic
current
avail
give
practic
physician
specif
etiolog
inform
rapidli
reason
cost
absenc
diagnost
facil
h
care
histori
physic
examin
gener
avail
laboratori
studi
enabl
physician
recogn
wide
varieti
clinic
syndrom
caus
virus
case
specif
viru
name
high
degre
accuraci
unfortun
mani
viral
diseas
produc
clinic
recogniz
syndrom
other
close
mimic
bacteri
infect
patient
viral
diagnost
studi
help
innumer
virus
known
caus
infect
human
be
virus
contain
either
deoxyribonucl
acid
dna
ribo
rna
permit
conveni
basi
classif
two
major
group
shown
tabl
classif
serv
use
purpos
sinc
close
relat
virus
share
characterist
may
determin
type
diseas
produc
may
nucleic
acid
type
determin
sensit
chemotherapeut
agent
one
approach
diagnosi
viral
infect
classifi
diseas
may
produc
singl
viru
herp
simplex
viru
exampl
capabl
produc
ill
may
involv
one
sever
organ
system
spectrum
sever
anoth
approach
classifi
diseas
accord
organ
system
involv
expand
includ
age
patient
season
year
possibl
enumer
virus
like
produc
ill
use
clinic
approach
diagnosi
viral
infect
virus
particularli
singl
serotyp
small
number
serotyp
gener
caus
infect
younger
patient
specif
antibodi
develop
mani
instanc
render
patient
perman
immun
measl
viru
good
exampl
singl
serotyp
diseas
highli
contagi
almost
children
measl
diseas
rare
adult
find
conveni
use
organ
syndrom
approach
first
anatom
diagnosi
acut
bronchiol
made
second
case
bronchiol
patient
usual
age
year
criteria
diagnosi
acut
bronchiol
met
may
almost
certain
diseas
caus
one
three
virus
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
season
factor
also
utmost
import
central
ohio
enterovirus
caus
infect
almost
exclus
april
novemb
virus
princip
caus
meningoenceph
summer
fall
arbovirus
transmit
arthropod
vector
therefor
diseas
caus
arbovirus
occur
vector
preval
vfruse
produc
certain
ill
children
characterist
may
diagnos
without
studi
diseas
measl
chickenpox
familiar
experienc
physician
care
children
seldom
question
reliabl
clinic
diagnosi
diseas
caus
virus
easili
recogn
clinic
may
familiar
childhood
diseas
describ
follow
section
virus
recogn
import
caus
ocular
infect
herp
simplex
varicellazost
vaccinia
mani
adenoviru
serotyp
caus
conjunct
frequent
part
primari
infect
complic
primari
infect
typic
ocular
manifest
includ
pain
photophobia
excess
tear
red
exud
occasion
infect
spread
involv
lid
associ
preauricular
lymphaden
infect
often
selflimit
symptomat
therapi
requir
keratoconjuncriwti
epidemi
keratoconjunct
caus
adenoviru
incub
period
thought
day
diseas
begin
sudden
onset
photophobia
excess
tear
red
edema
conjunctiva
preauricular
aden
usual
develop
within
sever
day
node
tender
diseas
initi
unilater
progress
eye
may
involv
conjunctiva
hobnail
appear
may
superfici
infiltr
cornea
discharg
serou
mueoid
patient
corneal
infiltr
may
ulcer
ulcer
may
persist
acut
phase
signific
proport
patient
epidem
keratoconjunct
membran
develop
may
requir
surgic
remov
superfici
inflammatori
corneal
opac
seen
may
persist
scar
conjunctiva
usual
asymptomat
also
occur
epidem
keratoconjunct
caus
adenoviru
may
acquir
ophthalmologist
offic
mani
patient
report
recent
visit
eye
doctor
day
prior
onset
infect
infect
prevent
meticul
handwash
steril
instrument
herpet
kerntiti
herpet
kerat
import
diseas
frequenc
unit
state
import
corneal
diseas
lead
loss
vision
may
occur
primari
diseas
associ
infect
strong
tendenc
recur
overal
recurr
rate
physician
believ
viru
remain
latent
sensori
nerv
cornea
becom
activ
varieti
precipit
factor
viru
frequent
found
lacrim
gland
viru
shed
frequent
absenc
diseas
corneal
lesion
characterist
branch
dendrit
appear
corneal
cloud
loss
visual
acuiti
fig
pain
examin
show
corneal
sensat
lost
clinic
diagnosi
made
high
degre
reliabl
herp
simplex
viru
may
recov
epitheli
serap
tear
recurr
infect
lead
stromal
involv
loss
visual
acuiti
rule
everi
patient
herp
kerat
flo
l
herpet
kerat
note
cloud
cornea
mark
conjunctiv
inject
order
see
dendrit
lesion
higher
magnif
must
use
lid
margin
also
involv
care
experienc
ophthalmologist
treatment
includ
chemotherapi
steroid
curettag
cauter
cryotherapi
even
best
care
risk
residu
damag
great
recurr
infect
spontan
heal
occur
patient
topic
steroid
without
concomit
chemotherapi
contraind
herp
infect
eye
practic
approach
dictat
topic
steroid
without
antibiot
never
use
eye
possibl
herp
simplex
viru
infect
exclud
respiratori
infect
among
common
infect
occur
children
virus
usual
caus
bacteri
upper
respiratori
infect
rel
uncommon
practic
import
recogn
infect
sinc
treatabl
antibiot
treatment
nonbacteri
upper
respiratori
infect
symptomat
anatom
etiolog
classif
upper
lower
respiratori
infect
present
tabl
upper
respiratori
infect
caus
virus
suffici
characterist
permit
recognit
clinic
includ
herpangina
herpet
gingivostomat
herp
labiali
herpangina
herpangina
summer
sore
throat
clinic
recogniz
syndrom
caus
sever
serotyp
coxsacki
virus
herpangina
common
caus
sore
throat
children
seen
warm
month
temper
climat
onset
abrupt
begin
fever
anorexia
usual
present
along
complaint
sore
throat
dysphagia
vomit
headach
abdomin
pain
uncommon
examin
earli
cours
diseas
reveal
erythema
throat
sometim
mild
edema
earli
appear
throat
characterist
day
characterist
small
papul
vesicl
red
areola
measur
mm
diamet
recogn
anterior
pillar
margin
soft
palat
uvula
less
commonli
tonsil
posterior
pharyng
wall
papular
vesicular
lesion
ulcer
within
hour
time
characterist
clearli
diagnost
punchedout
superfici
ulcer
usual
confin
structur
posterior
anterior
pillar
cervic
lymphadenopathi
common
node
present
small
nontend
earli
diseas
leukocyt
count
may
show
neutrophil
predomin
time
ulcer
lesion
seen
leukocyt
count
normal
low
throat
cultur
reveal
normal
flora
treatment
symptomat
diseas
characterist
run
cours
day
complic
uncommon
herpet
gingivostomat
herpet
gingivostomat
usual
primari
infect
herp
mplex
viru
type
infect
seen
commonli
age
year
though
may
occur
children
age
rare
adult
incub
period
day
diseas
begin
fever
day
patient
complain
sore
throat
shortli
thereaft
vesicl
may
found
involvd
mucosa
mouth
oral
mucou
membran
often
gener
erythemat
prior
develop
vesicl
progress
ulcer
anterior
cervic
lymph
node
becom
enlarg
tender
fever
increas
necrot
ulcer
may
seen
posterior
pharyng
wall
tonsil
tonsillar
pillar
soft
palat
tongu
buccal
mucosa
gingiva
gingiva
swollen
friabl
bleed
easili
odor
breath
characterist
quit
foul
mainten
oral
hygien
difficult
pain
persist
fever
temperatur
f
inabl
maintain
adequ
fluid
intak
often
lead
dehydr
may
requir
hospit
intraven
fluid
therapi
durat
diseas
day
fever
subsid
lysi
ulcer
lesion
excruciatingli
pain
becom
painless
heal
rapidli
complic
uncommon
herpet
lesion
may
found
elsewher
bodi
may
result
hematogen
dissemin
direct
inocul
fig
enceph
report
complic
diagnosi
seldom
present
difficulti
earli
prior
appear
ulcer
streptococc
pharyng
may
suspect
lesion
herpangina
usual
confin
structur
posterior
anterior
tonsillar
pillar
aphthou
stomat
seldom
associ
fever
number
ulcer
usual
less
treatment
symptomat
includ
attempt
maintain
good
oral
hygien
hydrat
usual
maintain
frequent
offer
bland
liquid
case
judici
use
analges
sed
may
necessari
keep
patient
comfort
permit
intak
adequ
fluid
maintain
hydrat
patient
herpet
gingivostomat
excret
larg
quantiti
viru
member
household
may
acquir
infect
young
infant
peculiarli
suscept
herp
infect
exposur
avoid
possibl
handfootandmouth
oiseas
handfootandmouth
diseas
origin
associ
coxsacki
probabl
caus
coxsacki
virus
well
occur
frequent
preschool
age
children
warm
month
often
epidem
fever
usual
low
grade
headach
anorexia
malais
sore
throat
common
manifest
gastroenter
may
occur
typic
oral
lesion
vesicl
surround
red
areola
vesicl
ruptur
leav
sharpli
punchedout
superfici
ulcer
found
part
mouth
pharynx
border
tongu
common
locat
total
number
lesion
usual
less
maculopapular
rash
involv
hand
feet
also
seen
superfici
vesiculopustular
oval
lesion
mm
diamet
surround
red
areola
develop
hand
feet
number
lesion
usual
less
fig
usual
durat
diseas
day
complic
unusu
herp
labiali
recurr
herp
labiali
usual
caus
herp
viru
hsv
type
infect
occur
age
group
precipit
multipl
factor
cold
fever
fro
patient
handfootandmouth
diseas
note
oval
vesicular
lesion
palm
finger
b
patient
ident
lesion
foot
toe
c
patient
ulcer
lesion
anterior
border
tongu
exposur
sunshin
menstruat
emot
upset
certain
bacteri
infect
caus
pneumococci
meningococci
lesion
may
occur
sporad
regular
basi
lesion
commonli
begin
vermilion
border
lower
lip
erythemat
patch
later
becom
vesicular
lesion
may
coalesc
form
cluster
involv
adjac
skin
mucosa
fig
sever
day
locul
lesion
ruptur
produc
straw
color
crust
also
may
hemorrhag
lesion
pain
frequent
associ
painfio
typic
appear
herp
labiali
cluster
vesicular
lesion
vermilion
border
hayn
r
e
spectrum
herp
simplex
viru
infect
children
south
med
j
press
ful
region
aden
usual
durat
day
lesion
heal
without
scar
format
effect
prophylact
therapeut
measur
known
etiolog
diagnosi
lower
respiratori
tract
infect
children
rare
establish
criteria
use
make
presumpt
etiolog
diagnosi
base
epidemiolog
studi
associ
viral
agent
clinic
infecti
syndrom
lower
respiratori
infect
caus
virus
suffici
characterist
permit
recognit
clinic
includ
croup
bronchiol
croup
croup
nonspecifi
term
indic
upper
aivay
obstruct
secondari
foreign
bodi
aspir
diphtherit
membran
haemophilu
influenza
type
b
epiglott
viral
laryngotrach
children
viral
croup
clinic
manifest
usual
allow
easi
identif
children
gener
year
age
preced
upper
respiratori
tract
ill
low
grade
fever
toxic
moder
leukocytosi
croup
character
distinct
cough
harsh
bark
qualiti
usual
intens
night
durat
ill
usual
day
although
may
persist
day
period
sever
respiratori
distress
hour
less
tremend
variabl
sever
viral
croup
children
mild
benign
cours
describ
children
progress
form
sever
h
influenza
epiglott
may
requir
either
tracheostomi
endotrach
intub
parainftuenza
virus
frequent
associ
viral
croup
agent
infect
larynx
produc
swell
inflamm
true
fals
cord
lead
upper
airway
obstruct
result
sign
symptom
children
recurr
episod
viral
croup
hypersensit
may
play
role
pathogenesi
rel
greater
sever
h
bfluenza
epiglott
extrem
import
abl
distinguish
epiglott
caus
croup
epiglott
common
children
year
age
character
sudden
onset
usual
interv
first
sign
symptom
signific
inspiratori
stridor
less
hour
histori
sore
throat
dysphagia
seen
physician
children
appear
toxic
acut
ill
agit
drool
hold
neck
ina
hyperextend
posit
breath
stridul
noisi
child
viral
croup
definit
diagnosi
made
enlarg
edemat
bright
red
epiglotti
observ
experienc
physician
control
condit
bronchiol
bronchiol
viral
infect
lower
respiratori
tract
diseas
young
children
year
age
character
preced
nonspecif
upper
respiratori
tract
symptom
low
grade
fever
subsequ
develop
brassi
cough
moderatetosever
respiratori
distress
examin
child
tachypn
anterior
posterior
diamet
chest
increas
expiratori
phase
respir
prolong
suprastern
intercost
retract
auscult
chest
wheez
rhonchi
andor
tale
present
lung
field
roentgenogram
chest
show
hyperinfl
flatten
diaphragm
air
bronchogram
fig
heart
rate
usual
increas
liver
edg
easili
palpabl
costal
margin
case
repres
heart
failur
appar
hepat
enlarg
caus
hyperinfl
chest
depress
diaphragm
virus
associ
bronchiol
rsv
parainfluenza
adenovirus
rsv
often
associ
bronehiol
children
month
age
may
repres
hypersensit
reaction
rsv
rsv
antibodi
relationship
bronchiol
infanc
develop
asthma
older
children
clear
know
howev
children
bronchiol
recurr
wheez
episod
year
initi
episod
bronchiol
rsv
also
appear
abl
precipit
wheez
asthmat
children
adenoviru
associ
sever
necrot
form
bronchiol
high
morbid
mortal
rate
mump
viru
caus
multisystem
diseas
mump
parot
clinic
distinguish
complic
mump
recogniz
associ
mump
parot
mump
acut
contagi
infect
manifest
pain
swell
parotid
gland
salivari
gland
central
nervou
system
cn
pancrea
test
may
involv
epidemiolog
mump
widespread
diseas
children
endem
world
spread
droplet
saliva
viru
may
found
saliva
day
day
salivari
gland
swell
viru
present
saliva
patient
orchiti
meningoenceph
without
appar
salivari
gland
swell
subclin
infect
detect
antibodi
respons
common
mump
diseas
occur
throughout
year
highest
incid
winter
earli
spring
pathogenesi
ihe
viru
multipli
first
cell
respiratori
tract
invad
blood
stream
local
salivari
gland
area
cn
test
pancrea
caus
inflammatori
respons
clinic
manifest
incub
period
day
onset
ill
usual
correspond
pain
swell
one
parotid
gland
soft
tissu
swell
enlarg
salivari
gland
readili
detect
sight
palpat
swell
seen
anterior
posterior
inferior
ear
ear
lobe
middl
swell
angl
mandibl
palpabl
swell
found
inferior
border
mandibl
wherea
cervic
aden
swell
found
earli
swell
soft
swell
progress
entir
area
becom
indur
fig
red
often
seen
around
open
stensen
duct
fever
usual
present
submandibular
sublingu
gland
may
involv
without
parot
prestern
edema
present
patient
fever
swell
usual
disappear
within
day
neurolog
manifest
mump
viru
singl
common
caus
meningoenceph
case
occur
least
period
given
geograph
area
count
mump
meningoenceph
may
preced
accompani
follow
involv
salivari
gland
hand
meningoenceph
may
sole
manifest
mump
infect
fio
patient
mump
demonstr
later
displac
ear
lobe
b
view
swell
seen
anterior
inferior
posterior
ear
ear
lobe
center
swollen
area
note
swell
mandibl
orcmxl
orchiti
rare
complic
puberti
occur
patient
puberti
incid
steril
bilater
orchiti
unknown
evid
suggest
mump
orchiti
unlik
caus
steril
symptom
orchiti
consist
pain
tender
swell
pain
earliest
symptom
occur
day
onset
salivari
gland
involv
testicular
swell
tender
last
averag
day
pancreat
epigastr
pain
vomit
common
manifest
pancreat
elev
serum
amylas
present
without
pancreat
salivari
gland
involv
therefor
indic
pancreat
complic
nephriti
thyroid
myocard
deaf
arthriti
thrombocytopen
purpura
rare
associ
matern
mump
infect
endocardi
fibroelastosi
fetu
postul
prove
parot
present
diagnosi
present
difficulti
inflamm
salivari
gland
associ
elev
serum
amylas
serum
amylas
level
usual
normal
patient
primari
meningoenceph
meningoenceph
accompani
parot
diagnosi
must
base
isol
etiolog
agent
demonstr
signific
rise
titer
complement
fix
cf
hemagglutinininhibit
hi
antibodi
sera
collect
acut
convalesc
phase
ill
isol
mump
viru
cell
cultur
cerebrospin
fluid
csf
patient
mump
meningoenceph
easili
accomplish
viru
isol
also
possibl
saliva
urin
serolog
diagnosi
mump
infect
possibl
basi
demonstr
cf
antibodi
v
viral
solubl
antigen
singl
serum
specimen
acut
stage
diseas
serum
contain
antibodi
antigen
neglig
antibodi
titer
v
antigen
convalesc
antibodi
demonstr
high
level
subsequ
month
decreas
faster
rate
v
particular
pattern
antibodi
permit
diagnosi
mump
infect
variou
stage
ill
treatment
prophylaxl
wreatment
usual
symptomat
although
ill
usual
sever
sequela
rare
orchiti
occur
approxim
postpubert
male
constitut
reason
justif
prophylaxi
live
attenu
mump
vaccin
prove
efficaci
recommend
purpos
highest
prioriti
place
immun
prepubert
adolesc
adult
male
neg
histori
pump
hyperimmun
globulin
inactiv
vaccin
effect
recommend
addit
clinic
recogniz
diseas
caus
virus
mani
ill
viral
etiolog
strongli
suspect
use
select
laboratori
test
usual
avail
physician
yield
inform
support
clinic
impress
instanc
cours
ill
support
probabl
viral
etiolog
follow
section
devot
discuss
diseas
coimon
cold
common
cold
selflimit
infect
seen
season
peak
incid
winter
adult
rhinovirus
probabl
account
cold
children
rhinovirus
less
commonli
implic
wherea
virus
particularli
rsv
parainfluenza
viru
adenoviru
common
etiolog
agent
primari
symptom
nasal
discharg
symptom
variabl
temperatur
exceed
f
unusu
constitutionalsyruptom
headach
myalgia
sore
throat
anorexia
may
present
particularli
nasopharynx
involv
examin
reveal
low
grade
fever
congest
nasal
mucosa
nasal
discharg
may
either
mucoid
mucopurul
pharynx
involv
usual
diffus
erythema
pharynx
cervic
lymph
node
minim
enlarg
usual
nontend
infant
upper
respiratori
infect
nasal
obstruct
may
develop
suffici
produc
respiratori
distress
sinc
earli
life
oblig
nasal
breather
patient
relief
nasal
obstruct
gentl
suction
instil
steril
normal
salin
judici
use
decongest
phenylephrin
may
result
dramat
relief
respiratori
distress
use
decongest
oral
also
may
give
symptomat
relief
intim
relationship
middl
ear
paranas
sinus
nasopharynx
predispos
infect
structur
open
becom
obstruct
mucos
edema
secret
lower
respiratori
tract
also
may
involv
extens
infect
adenovlr
ptlaryng
multipl
serotyp
adenoviru
associ
pharyng
adenoviru
common
clinic
pictur
produc
differ
serotyp
similar
adeuovir
pharyng
describ
epidem
form
among
militari
recruit
occur
children
age
incub
period
day
ill
develop
period
sever
day
character
fever
sore
throat
anorexia
nausea
headach
hoars
cough
frequent
often
conjunct
promin
find
examin
throat
may
red
lymphoid
hyperplasia
easili
recogn
posterior
pharyng
wall
exud
may
present
either
posterior
pharyng
wall
tonsil
exud
may
superimpos
lymphoid
follicl
tonsil
spars
occur
small
grayish
white
follicl
inflamm
nasal
mucosa
often
present
conjunct
may
either
unilater
bilater
seldom
sever
palpebr
conjunctiva
often
involv
follicular
appear
usual
excess
tear
purul
discharg
uncommon
conjunct
present
preauricular
lymphadenopathi
may
recogn
cervic
lymphadenopathi
may
present
appear
later
streptococc
pharyng
node
seldom
moder
enlarg
either
nontend
mildli
tender
complet
syndrom
refer
pharyngoconjunctiv
fever
conjunct
present
help
diagnosi
leukocyt
count
usual
within
normal
limit
primari
respons
exclud
streptococc
pharyng
best
accomplish
throat
cultur
yield
normal
flora
natur
cours
ill
seldom
extend
day
fever
fluctuat
temperatur
f
gradual
disappear
symptom
subsid
acut
inflammatori
chang
pharynx
conjunctiva
treatment
entir
symptomat
acetylsalicyl
acid
acetaminophen
may
use
control
fever
conjunct
seldom
requir
therapi
though
collyrium
may
use
complic
otiti
media
sinus
lower
respiratori
tract
infect
may
follow
decongest
without
antihistamin
often
use
effort
prevent
complic
proof
efficaci
lack
acut
lymphonodular
pharyng
diseas
recogn
children
caus
coxsacki
symptom
includ
fever
headach
sore
throat
diseas
recogn
discret
nodular
lesion
uvula
anterior
pillar
posterior
pharyng
wall
nodul
cover
whitish
yellowish
exud
ulcer
diseas
usual
persist
week
treatment
symptomat
complic
rare
pneumonia
clinic
diagnosi
viral
pneumonia
usual
made
exclud
bacteri
mycoplasma
pneumonia
sinc
diagnosi
viral
pneumonia
difficult
establish
certainti
etiolog
diagnosi
bacteri
pneumonia
hinder
difficult
obtain
specimen
cultur
site
patholog
diagnost
procedur
short
lung
biopsi
lung
aspir
indirect
diagnost
technic
blood
cultur
help
posit
patient
posit
blood
cultur
sputum
specimen
difficult
obtain
young
children
collect
contamin
saliva
nasopharyng
throat
cultur
littl
valu
lower
respiratori
tract
pathogen
found
upper
respiratori
tract
patient
without
diseas
recoveri
pneumococcu
exampl
nasopharyng
cultur
child
pneumonia
indic
colon
upper
respiratori
tract
pneumococcu
establish
pneumococcu
caus
pneumonia
clinic
guidelin
use
diagnosi
bacteri
pneumonia
establish
studi
two
group
patient
first
group
compris
presum
pneumococc
pneumonia
sputum
contain
polymorphonuclear
cell
gramposit
lancetshap
diplococci
patient
usual
respond
promptli
penicillin
therapi
second
group
patient
compris
posit
cultur
blood
lung
tissu
empyema
fluid
guidelin
allow
separ
pneumonia
two
gener
categori
bacteri
nonbacteri
bacteri
pneumococc
pneumonia
frequent
bacteri
pneumonia
children
frequenc
pneumonia
caus
h
bzfluenza
well
establish
pneumonia
caus
staphylococcu
attrett
occur
frequent
neonat
period
first
year
life
patient
predispos
factor
common
predispos
factor
includ
underli
diseas
malign
measl
influenza
varicella
factor
hospit
exposur
antibiot
therapi
staphylococc
infect
patient
exposur
staphylococc
infect
environ
clinic
pictur
bacteri
pneumonia
character
toxic
respiratori
distress
manifest
tachypnea
tachycardia
alar
flare
use
accessori
muscl
respir
sign
usual
sudden
onset
progress
sever
leukocyt
count
markedli
elev
predomin
polymorphonuclear
cell
physic
examin
chest
particularli
younger
children
reveal
abnorm
evid
bronchospast
diseas
usual
absent
roentgenogram
often
reveal
pleural
effus
lobar
consolid
pneumatocel
blood
cultur
posit
patient
staphylococc
pneumonia
tend
rapidli
progress
destruct
even
adequ
antibiot
therapi
wherea
pneumococc
pneumonia
respond
rapidli
penicillin
therapi
absenc
effus
patient
treat
earli
asymptomat
hour
nonbacteri
child
nonbacteri
pneumonia
clinic
pictur
differ
onset
gradual
pneumonia
usual
preced
sever
day
nonspecifi
upper
respiratori
tract
symptom
gradual
progress
respiratori
distress
cough
physic
examin
often
numer
tale
rhonchi
occasion
wheez
good
gener
rule
patient
nonbacteri
pneumonia
abnorm
physic
find
chest
children
bacteri
pneumonia
child
rel
less
toxic
leukocyt
count
usual
less
nonbacteri
pneumonia
local
one
lobe
may
involv
lobe
bronchopneumon
type
distribut
pleural
fluid
accumul
extrem
rare
antibiot
therapi
produc
signific
improv
hour
usual
neither
clinic
roentgenograph
evid
progress
pneumonia
child
pneumonia
exclus
bacteri
pneumonia
verifi
diagnosi
viral
pneumonia
mycoplasma
pneumonia
clinic
laboratori
featur
indistinguish
viral
pneumonia
mycoplasma
pneumonia
howev
frequent
occur
epidem
among
children
school
age
older
theserolog
test
readili
avail
diagnosi
mycoplasma
pneumonia
cold
agglutinin
nonspecif
mycoplasma
cf
test
specif
cold
agglutinin
test
posit
patient
mycoplasma
pneumonia
provid
presumpt
evid
diagnosi
sinc
mycoplasma
cf
test
specif
provid
epidemiolog
data
preval
mycoplasma
infectionsin
commun
diagnosi
specif
viral
pneumonia
influenza
strongli
suspect
epidem
diagnosi
viral
pneumonia
made
recoveri
viru
site
patholog
infltjenza
influenza
acut
respiratori
infect
caus
one
influenza
virus
type
b
c
influenza
b
c
myxovirus
subclassifi
orthomyxovirus
three
major
type
immunolog
distinct
crossimmun
epidemiolog
influenza
b
respons
outbreak
diseas
influenza
c
rare
produc
clinic
diseas
sporad
associ
outbreak
major
antigen
variat
influenza
occur
past
decad
basi
extern
antigen
neuraminidas
hemagglutinin
four
major
subtyp
influenza
recogn
aswin
preval
influenza
influenza
influenza
hong
kong
strain
present
time
antigen
variat
also
occur
surfac
antigen
influenza
b
viru
especi
demonstr
recent
isol
influenza
b
virus
antigen
chang
major
shift
suffici
magnitud
warrant
distinct
subtyp
major
antigen
shift
influenza
virus
utmost
epidemiolog
import
shift
occur
new
viru
replac
earlier
strain
make
exist
vaccin
ineffect
individu
immun
previou
viru
suscept
new
strain
introduct
new
major
strain
pandem
epidem
influenza
sweep
rapidli
suscept
popul
caus
consider
econom
loss
high
morbid
mortal
especi
elderli
young
popul
acquir
immun
new
viru
variant
epidem
declin
magnitud
major
popul
immun
usual
span
year
immun
inhibit
surviv
viru
therefor
replac
new
variant
emerg
new
variant
strain
make
prevent
control
diseas
difficult
virus
spread
direct
contact
via
respiratori
secret
attack
rate
highest
school
age
children
presum
due
greater
risk
exposur
temper
climat
definit
season
incid
highest
attack
rate
winter
month
symptom
sign
incub
period
day
epidem
spectrum
clinic
diseas
observ
major
case
asymptomat
recogn
viral
isol
antibodi
respons
onset
symptomat
case
abrupt
malais
myalgia
headach
chill
fever
cough
substern
burn
nasal
discharg
sore
throat
combin
symptom
found
vari
intens
total
durat
uncompl
diseas
day
mani
patient
feel
debilit
time
recoveri
common
complic
respons
major
death
epidem
influenza
pneumonia
pneumonia
may
caus
influenza
viru
secondari
bacteri
agent
complic
frequent
encount
children
heart
diseas
elderli
patient
chronic
lung
diseas
organ
commonli
respons
secondari
bacteri
pneumonia
diplococctt
pnettmonia
staphylococcu
attreu
pneumonia
caus
influenza
viru
associ
dyspnea
tachycardia
product
cough
often
bloodi
sputum
sever
case
cyanosi
may
present
xray
show
diffus
bronchopneumonia
epidemiolog
associ
epidem
influenza
b
diseas
rey
syndrom
note
treatment
treatment
consist
bed
rest
analges
fluid
antibiot
valu
treatment
uncompl
influenza
secondari
bacteri
pneumonia
treat
appropri
antibiot
prevent
ill
may
prevent
immun
influenza
vaccin
chemotherapi
vacchl
influenza
vaccin
present
avail
bival
contain
current
b
antigen
viru
product
vaccin
propag
egg
inactiv
bival
vaccin
use
right
time
afford
protect
clinic
influenza
vaccin
given
parenter
effect
produc
circul
antibodi
secretori
immunoglobulin
iga
respiratori
tract
durat
protect
brief
repeat
booster
requir
usual
annual
basi
minor
antigen
chang
occur
influenza
virus
season
season
make
current
vaccin
less
effect
reduct
vaccin
effici
minim
vaccin
ineffect
major
antigen
shift
vaccin
epidem
viru
signific
properti
viru
antigen
labil
requir
prepar
new
vaccin
contain
recent
mutant
strain
influenza
selflimit
diseas
otherwis
healthi
child
adult
sinc
protect
afford
vaccin
transient
vaccin
influenza
recommend
routin
vaccin
recommend
person
age
underli
bronchopulmonari
cardiovascular
renal
diseas
studi
live
attenu
aerosol
vaccin
viru
parenter
inject
necessari
stimul
superior
iga
respons
carri
addit
inform
vaccin
purifi
subunit
vaccin
contain
influenza
hemagglutinin
great
interest
clzemotherapi
amantadin
synthet
antivir
agent
shown
effect
prevent
influenza
infect
ineffect
prevent
influenza
b
infect
thought
prevent
penetr
viru
cell
drug
must
administ
prophylact
long
threat
exposur
exist
along
toxic
effect
limit
use
drug
gener
public
drug
high
dose
may
caus
cn
toxic
hyperexcit
tremor
slur
speech
ataxia
psychot
reaction
convuls
viral
myocard
viral
myoearditi
often
suspect
infant
children
diagnosi
difficult
establish
certainti
virus
associ
myocardifi
children
includ
coxsaeki
echo
adenoviru
varicellazost
epsteinbarr
eb
mump
rubella
rubeola
cytomegaloviru
cmv
polio
multipl
etiolog
agent
associ
viral
myocard
everpres
possibl
rheumat
myocard
unequivoc
diagnosi
difficult
howev
sever
clinic
diagnost
point
use
make
presumpt
etiolog
diagnosi
coxsaeki
b
virus
frequent
caus
viral
myocard
produc
clinic
featur
easili
identifi
transmiss
viru
infant
occur
either
across
placenta
oralfec
rout
evid
transplacent
transmiss
agent
come
studi
coxsacki
viru
recov
stillborn
infant
studi
infant
becam
ill
within
hour
deliveri
viru
isol
placenta
histologi
evid
placent
infect
demonstr
coxsaeki
b
viru
frequent
present
stool
specimen
infect
patient
therefor
fecal
contamin
vagina
uteru
fetoplacent
membran
could
produc
infect
infant
direct
extens
report
children
coxsaeki
b
viru
myoearditi
review
describ
clinic
epidemiolog
featur
neonat
form
common
account
patient
review
coxsacki
b
myoearditi
occur
neonat
period
sever
distinguish
clinic
featur
often
evid
coxsaeki
b
viru
infect
commun
mother
mother
eight
infant
myocard
first
week
life
either
coryza
fever
andor
pleurodynia
diseas
usual
develop
first
week
life
patient
sign
symptom
neonat
myocard
similar
neonat
sepsi
includ
fever
lethargi
irrit
seizur
tachypnea
tachycardia
hepatosplenomegali
cardiomegali
constant
clinic
featur
howev
congest
heart
failur
system
cardiovascular
frequent
involv
patient
either
meningoenceph
hepat
pneumonia
prognosi
poor
report
fatal
rate
neonat
coxsacki
b
myocard
coxsacki
b
viral
myocard
older
children
difficult
differenti
type
myocard
clinic
indistinguish
echo
viru
myocard
reason
discuss
togeth
season
factor
import
sinc
coxsacki
b
virus
echo
virus
enterovirus
within
picornaviru
group
rna
virus
gener
produc
diseas
warm
weather
patient
enterovir
myocard
nine
ill
develop
novemb
march
ill
children
biphas
first
phase
usual
character
either
nonspecif
upper
respiratori
gastrointestin
infect
follow
week
later
sign
symptom
congest
heart
failur
meningoenceph
may
occur
near
time
develop
myocard
report
echo
viru
coxsacki
b
viru
myocard
involv
myocardium
cn
child
summer
month
presumpt
evid
enterovir
myocard
opportun
studi
ill
child
echo
myocard
meningoenceph
includ
case
detail
illustr
clinic
manifest
case
report
caucasian
boy
admit
seizur
infant
well
day
admiss
develop
fever
anorexia
day
admiss
gener
seizur
termin
administr
diazepam
intraven
immedi
afterward
respiratori
arrest
occur
resuscit
puls
respir
flush
blood
pressur
mm
hg
soft
grade
systol
murmur
left
sternal
border
heart
sound
describ
muffl
liver
edg
palpabl
cm
right
costal
margin
chest
roentgenogram
reveal
markedli
enlarg
heart
ecg
show
low
voltag
lead
serum
enzym
studi
reveal
lactic
dehydrogenas
activ
unitsml
sgot
unitsml
heart
scan
use
pertechnet
reveal
pattern
consist
pericardiai
effus
two
week
later
repeat
heart
scan
normal
csf
time
admiss
contain
leukocyt
erythrocytescu
mm
protein
ml
glucos
ml
echo
viru
type
recov
specimen
second
csf
specimen
obtain
day
admiss
ventil
maintain
bennett
respir
congest
heart
failur
control
oxygen
digoxin
ethacryn
acid
systol
murmur
heard
initi
disappear
aqueou
penicillin
g
unitskgday
given
intraven
kanamycin
mgkgday
administ
intramuscularli
dexamethason
mg
daili
given
first
hospit
day
patient
improv
slowli
follow
resumpt
spontan
respir
discharg
week
admiss
chest
roentgenogram
show
larg
cardiac
silhouett
day
admiss
normal
size
heart
week
discharg
fig
adenoviru
also
associ
myocard
children
less
frequent
enterovirus
adenoviru
myocard
fxg
mark
cardiomegali
day
admiss
b
roentgenogram
week
later
heart
size
return
normal
develop
children
year
age
associ
infect
upper
lower
respiratori
tract
clinic
featur
nonspecif
primarili
congest
heart
failur
virus
associ
myocard
mump
varicellazost
eb
viru
cmv
rubella
rubeola
virus
produc
rather
typic
clinic
diseas
myocard
usual
complic
primari
diseas
presumpt
clinic
etiolog
diagnosi
myocard
depend
upon
epidemiolog
clinic
data
echo
coxsacki
viru
infect
like
occur
summer
month
wherea
etiolog
agent
mention
occur
time
year
coxsacki
viru
myocard
would
suspect
neonat
myocard
meningoenceph
hepat
especi
pleurodynia
coxsacki
b
infect
preval
echo
viru
myocard
would
like
occur
summer
month
also
usual
associ
neonat
infect
would
like
occur
older
child
either
follow
nonspecif
upper
respiratori
infect
perhap
associ
meningoenceph
adenoviru
myocard
could
occur
time
year
would
probabl
preced
nonspecif
respiratori
tract
ill
diagnost
procedur
includ
attempt
viru
isol
serolog
studi
unfortun
etiolog
diagnosi
may
prove
final
diagnosi
must
base
clinic
criteria
alon
role
virus
caus
myocard
children
clearli
establish
infant
virus
much
import
older
children
born
mind
rheumat
fever
still
singl
import
caus
myocard
children
differenti
rheumat
viral
myocard
usual
present
littl
difficulti
rheumat
fever
myocard
unusu
children
year
age
usual
occur
associ
rheumat
manifest
signific
murmur
acut
infecti
nonbacteri
diarrhea
occur
sporad
epidem
form
often
term
viral
gastroenter
although
coxsacki
echo
adenovirus
associ
gastroenter
major
case
nonbacteri
gastroenter
etiolog
unexplain
acut
infecti
nonbacteri
gastroenter
gener
selflimit
character
symptom
low
grade
fever
nausea
vomit
abdomin
cramp
diarrhea
recent
studi
indic
caus
diseas
may
virus
cultiv
identifi
electron
microscopi
duoden
mucosa
patient
acut
gastroenter
studi
human
volunt
ingest
stool
filtrat
contain
norwalk
agent
shown
clinic
ill
develop
lesion
mucosa
proxim
small
intestin
orbivirus
group
close
relat
reovirus
shown
associ
gastroenter
children
viral
particl
identifi
epitheli
cell
duoden
mucosa
along
histolog
chang
mucosa
depress
disaccharidas
activ
obvious
exact
import
agent
caus
gastrdenter
await
clarif
virus
frequent
caus
acut
meningoenceph
children
shown
tabl
asept
meningoenceph
may
describ
term
csf
find
follow
leuko
cyte
fewer
per
cu
mm
usual
necessarili
predominantli
mononuclear
cell
normal
glucos
protein
content
neg
smear
cultur
bacteria
fungi
except
neonat
normal
valu
fewer
leukocyt
per
cu
mm
glucos
mg
approxim
two
third
serum
glucos
valu
protein
content
mg
less
mani
noninfecti
diseas
nonvir
infect
may
caus
csf
find
asept
meningoenceph
may
caus
varieti
etiolog
agent
pursuit
specif
etiolog
agent
avoid
delay
recognit
treatment
diseas
constitut
seriou
threat
life
welfar
children
mump
viru
perenni
basi
singl
frequent
caus
asept
meningoenceph
diseas
occur
season
parot
without
parot
patient
may
appear
quit
sick
toxic
lumbar
punctur
often
follow
impress
remiss
symptom
temper
climat
enterovirus
frequent
caus
asept
meningoenceph
occur
almost
exclus
april
novemb
three
type
polioviru
mani
echo
viru
serotyp
coxsacki
b
virus
caus
infect
gener
rel
mild
diseas
unassoci
focal
neurolog
sign
durat
usual
less
week
sequela
rare
enterovirus
serotyp
produc
simultan
epidem
asept
meningoenceph
mani
wide
separ
part
countri
gener
clinic
characterist
ill
similar
irrespect
group
serotyp
viru
practic
purpos
particular
advantag
identif
viru
beyond
recognit
enteroviru
true
polioviru
often
produc
benign
cn
ill
though
clinic
manifest
may
includ
anterior
born
cell
diseas
asymmetr
flaccid
paralysi
bulbar
diseas
enceph
enterovirus
may
rare
caus
poliolik
diseas
specif
neurolog
deficit
echo
coxsacki
virus
frequent
isol
csf
hsv
import
caus
cn
infect
viru
probabl
caus
spectrum
ill
term
sever
may
caus
diseas
age
group
benign
asept
meningoenceph
caus
hsv
clinic
indistinguish
meningoencephalitid
unfortun
howev
hsv
also
caus
sever
enceph
high
case
fatal
rate
high
incid
seriou
perman
neurologi
sequela
among
survivor
ill
occur
season
initi
symptom
usual
fever
headach
vomit
follow
rapidli
progress
alter
sensorium
lethargi
delirium
semicoma
coma
focal
neurolog
sign
includ
cranial
nerv
palsi
weak
paresi
abnorm
reflex
focal
seizur
common
sever
pictur
rapidli
progress
neurolog
deterior
occur
period
day
csf
find
earli
typic
seen
viral
meningitid
erythrocyt
often
found
diseas
progress
csf
pressur
rise
protein
content
may
increas
rapidli
viru
almost
never
recov
csf
electroencephalogram
reveal
delta
activ
cycl
per
second
spike
activ
concord
hemiparesi
seizur
brain
scan
may
show
increas
uptak
often
tempor
lobe
pattern
also
may
resembl
doughnut
appear
characterist
brain
abscess
central
area
decreas
uptak
surround
circumferenti
area
increas
uptak
carotid
angiographi
may
reveal
vascular
displac
suggest
mass
lesion
tumor
abscess
diagnosi
prove
brain
biopsi
focal
area
delin
prior
studi
specimen
examin
histopatholog
chang
consist
enceph
specif
presenc
intranuclear
inclus
bodi
specimen
also
inocul
cell
cultur
experi
cytopatholog
characterist
hsv
may
recogn
hour
inocul
th
present
treatment
herp
enceph
consist
support
care
attempt
control
intracrani
hypertens
secondari
cerebr
edema
perhap
chemotherapi
iododeoxyuridin
ba
tri
vari
report
efficaci
howev
consensu
drug
toxic
continu
trial
second
drug
adenin
arabinosid
studi
yet
data
concern
efficaci
avail
though
preliminari
studi
suggest
signific
toxic
present
diagnosi
possibl
brain
biopsi
procedur
without
risk
carri
hospit
without
seriou
complic
sever
herp
enceph
continu
studi
promis
chemotherapeut
agent
fulli
justifi
order
result
may
evalu
diagnosi
must
confirm
biopsi
therapi
must
begun
prior
develop
irrevers
brain
damag
arboviru
caus
enceph
central
ohio
california
enceph
viru
viru
transmit
human
mosquito
therefor
diseas
occur
primarili
summer
earli
fall
fever
headach
vomit
initi
symptom
follow
lethargi
disorient
sever
case
semicoma
coma
seizur
occur
patient
onset
diseas
tend
rapidli
progress
focal
neurolog
sign
facial
weak
focal
seizur
transient
hemiparesi
common
earli
diseas
resembl
herp
enceph
howev
patient
california
enceph
may
show
improv
day
wherea
herp
enceph
show
progress
neurolog
deterior
csf
find
characterist
asept
mening
electroencephalographi
show
gener
cerebr
dysfunct
evid
local
brain
scan
may
normal
may
demonstr
increas
uptak
suggest
focal
lesion
diagnosi
base
serolog
test
hi
cf
durat
ill
usual
day
patient
recov
complet
although
display
emot
labil
period
sever
month
patient
present
cn
infect
associ
csf
find
compat
asept
meningoenceph
diseas
variabl
etiolog
primari
respons
physician
identifi
treatabl
diseas
must
consid
season
factor
histori
exposur
immun
histori
along
care
document
onset
progress
ill
care
physic
examin
includ
detail
neurologi
examin
essenti
lumbar
punctur
open
close
pressur
determin
csf
content
also
essenti
particular
csf
find
view
suspicion
cell
count
higher
expect
protein
content
higher
glucos
content
lower
expect
repeat
lumbar
punctur
perform
hour
first
may
great
valu
bacteri
infect
usual
produc
progress
csf
chang
wherea
viral
infect
produc
signific
chang
csf
short
period
herp
simplex
viru
infect
hsv
may
produc
sever
rapidli
progress
neonat
infect
viru
transmit
infant
sever
way
intrauterin
infect
may
occur
secondari
matern
viremia
usual
method
acquir
infect
passag
infant
infect
birth
canal
usual
site
matern
infect
chronic
cervic
third
method
acquir
infect
exposur
person
activ
herpet
infect
herp
labiali
gingivostomat
recurr
infect
skin
neonat
infect
acquir
secondari
matern
viremia
may
caus
hsv
type
hsv
type
infect
acquir
passag
birth
canal
caus
environment
sourc
may
either
type
transplacent
infect
earli
pregnanc
may
result
fetal
wastag
anomali
intrauterin
infect
latter
part
pregnanc
result
clinic
pictur
neonat
sepsi
compar
caus
etiolog
agent
bacteria
cmv
toxoplasma
gondii
rubella
viru
infant
usual
small
gestat
age
present
jaundic
hepatosplenomegali
seizur
lethargi
poor
feed
vesicular
skin
lesion
often
zosteriform
distribut
fig
infect
acquir
birth
may
becom
clinic
manifest
sever
day
later
initi
symptom
poor
feed
temperatur
instabl
lethargi
follow
rapid
develop
fullblown
clinic
pictur
sepsi
without
enceph
find
even
singl
vesicl
viru
easili
recov
suggest
dissemin
herpet
infect
rapid
deterior
patient
condit
characterist
complic
dissemin
intravascular
coagul
circulatori
respiratori
collaps
destruct
brain
frequent
patient
enceph
csf
abnorm
increas
leukocyt
elev
protein
content
protein
content
csf
usual
continu
rise
infant
peculiarli
suscept
herp
infect
infect
result
either
death
sever
neurolog
sequela
surviv
satisfactori
treatment
dissemin
neonat
herpet
infect
meticul
support
care
treatment
complic
necessari
treatment
adenin
arabinosid
studi
yet
inform
avail
effect
method
deal
neonat
herpet
infect
prevent
activ
herp
infect
birth
canal
term
indic
cesarean
section
also
import
avoid
exposur
neonat
hsv
home
hospit
environ
neonat
herpet
infect
diagnos
suspect
one
earliest
clue
diagnosi
appear
one
vesicular
skin
lesion
found
lesion
cultur
chemotherapi
use
start
await
con
firmat
recoveri
viru
lesion
report
dissemin
neonat
herpet
infect
follow
favor
outcom
absenc
chemotherapi
gener
dissemin
neonat
infect
without
enceph
carri
grave
prognosi
human
cmv
ubiquit
agent
dna
core
ieosahedr
capsid
measur
like
member
herpesvirus
cmv
commonli
produc
latent
andor
chronic
infect
cytomegal
inclus
diseas
seen
infanc
result
intrauterin
infect
adult
older
children
cmv
infect
appear
latent
becom
appar
patient
impair
host
respons
cmv
infect
recogn
increas
frequenc
patient
neoplasm
immunosuppress
recipi
organ
transplant
patient
viru
frequent
caus
acut
pneumonia
hepat
cmv
mononucleosi
character
malais
myalgia
fever
lymphocytosi
abnorm
liver
function
serolog
test
neg
infecti
mononucleosi
syndrom
describ
patient
transfus
heart
surgeri
well
previous
healthi
individu
viru
isol
urin
patient
congenit
acquir
infect
viru
transmit
transplacent
mother
primari
cmv
infect
fetu
transmiss
occur
regardless
stage
pregnanc
larg
scale
studi
shown
incid
neonat
infect
matern
infect
first
trimest
associ
multipl
organ
involv
includ
cn
microcephali
cerebr
calcif
although
mother
may
excret
viru
indefinit
period
time
subsequ
pregnanc
usual
unaffect
protect
appar
due
matern
antibodi
acquir
initi
infect
clinic
featur
neonat
c
v
infect
vari
frank
involv
multipl
organ
intrauterin
growth
retard
hepatosplenomegali
jaundic
hepat
petechia
thrombocytopenia
microcephali
cerebr
calcif
chorioretin
minim
abnorm
transient
thrombocytopenia
complet
lack
symptom
excret
viru
fig
infant
cmv
diseas
excret
viru
urin
period
month
sever
year
protract
period
viral
shed
serv
sourc
dissemin
diacnosi
sensit
method
diagnosi
cmv
infect
isol
viru
patient
urin
viru
isol
throat
blood
tissu
specimen
viru
cultur
human
fibroblast
caus
focal
lesion
follow
appear
larg
intranuclear
eosinophil
inclus
bodi
detect
inclus
bodi
epitheli
cell
urinari
sediment
also
repres
valuabl
diagnost
test
fit
typic
appear
infant
sever
congenit
infect
rubella
cytomegal
inclus
diseas
head
normal
size
note
rel
small
bodi
wrinkl
skin
indic
absenc
subcutan
fat
blueberri
muffin
lesion
secondari
bleed
skin
r
detect
specif
cmv
immunoglobulin
igm
antibodi
indirect
immunofluoresc
help
diagnost
aid
symptomat
patient
test
often
neg
asymptomat
infant
excret
viru
treatment
although
antivir
agent
adenin
arabinosid
propos
treatment
infect
efficaci
unprov
method
prevent
avail
rubella
occur
first
trimest
pregnanc
associ
high
incid
congenit
anomali
well
fetal
wastag
risk
matern
rubella
caus
anomali
greatest
first
week
pregnanc
decreas
next
week
infant
congenit
rubella
remark
similar
either
congenit
dissemin
neonat
herp
cytomegal
inclus
diseas
infant
small
gestat
age
markedli
decreas
subcutan
fat
hepatosplenomegali
jaundic
alter
sensorium
neurolog
abnorm
impair
coagul
bleed
skin
produc
characterist
blueberri
muffin
lesion
see
fig
addit
pictur
neonat
sepsi
enceph
stigmata
rubella
syndrom
help
differenti
infant
sever
congenit
infect
common
defect
congenit
heart
lesion
patent
ductu
arteriosu
endocardi
cushion
defect
cataract
microcephali
defect
sensorineur
deaf
congenit
cataract
may
recogn
later
laboratori
studi
reveal
increas
bilirubin
primarili
indirect
react
fraction
thrombocytopenia
abnorm
csf
includ
increas
leukocyt
elev
protein
content
igm
level
elev
demonstr
signific
level
antibodi
rubella
fraction
diagnost
specif
diagnosi
made
recoveri
viru
infant
antibodi
studi
diagnost
sinc
matern
antibodi
cross
placenta
etiolog
eb
viru
implic
caus
infecti
mononucleosi
although
neither
isol
patient
diseas
grown
cell
cultur
patient
recov
mononucleosi
antibodi
develop
react
viral
particl
found
cell
line
deriv
burkitt
lymphoma
sever
studi
document
protect
effect
eb
viral
antibodi
develop
diseas
eb
viru
demonstr
electron
microscopi
immunofluoresc
cultur
blood
leukocyt
taken
patient
recoveri
mononucleosi
transform
factor
isol
throat
secret
patient
infecti
mononucleosi
factor
capabl
transform
cord
blood
leukocyt
continu
cell
line
activ
neutral
specif
eb
antibodi
detect
late
month
onset
symptom
induct
diseas
eb
viru
inocul
suscept
host
indirectli
report
studi
approach
concern
untoward
result
koch
postul
remain
unfulfil
relationship
infecti
mononucleosi
eb
viru
clearli
demonstr
clinic
pictur
forti
year
ago
tidi
describ
three
clinic
present
mononucleosi
glandular
form
character
short
prodrom
period
follow
enlarg
group
lymph
node
without
accompani
constitut
symptom
anginos
form
pharyng
inject
membran
format
febril
form
seen
adult
malais
fever
headach
frequent
chill
lymph
node
enlarg
may
occur
time
ill
third
form
classic
triad
fever
exud
pharyng
adenopathi
may
present
patient
earli
symptom
nonspecif
patient
experienc
malais
low
grade
fever
headach
sore
throat
fever
rang
f
subsid
day
major
patient
relaps
day
without
fever
rare
posterior
cervic
lymph
node
enlarg
differenti
mononucleosi
caus
cervic
adenopathi
node
bilater
discret
usual
nontend
nonsuppur
may
produc
bullneck
appear
axillari
inguin
adenopathi
may
present
end
first
week
throat
becom
diffus
inject
membran
exud
tonsil
palat
enanthem
consist
crop
sharpli
circumscrib
petechia
uvula
soft
palat
uvula
appear
day
secondari
infect
fusobacteria
hemolyt
streptococci
give
breath
foul
odor
sever
hyperplasia
nasopharyng
lymphoid
tissu
caus
nasal
obstruct
secret
give
nasal
qualiti
voic
may
lead
refus
swallow
water
even
saliva
fig
rare
sever
lymphoid
hyperplasia
may
produc
tracheal
compress
requir
tracheostomi
face
frequent
puffi
edema
eyelid
hepatosplenomegali
common
splenomegali
may
persist
month
skin
rash
usual
maculopapular
sometim
petechi
vesicular
urticari
morbilliform
scarlatiniform
occur
patient
young
children
year
age
seem
symptom
describ
often
present
gastroenter
bronchopneumonia
hepatosplenomegali
heterophil
titer
often
neg
diagnosi
made
detect
specif
antibodi
eb
viru
fro
typic
appear
neck
caus
lymphadenopathi
infecti
mononucleosi
b
patient
infecti
mononucleosi
sever
nasal
obstruct
drool
caus
refus
swallow
patient
treat
steroid
increas
respiratori
distress
secondari
mark
tonsillar
adenoid
hypertrophi
infecti
mononucleosi
may
present
unusu
manifest
hepat
urticaria
hemolyt
anemia
purpura
palmar
dermat
carditi
arthriti
variou
neurolog
abnorm
unusu
present
may
delay
correct
diagnosi
manifest
usual
resolv
complet
cours
diseas
though
may
rare
lead
seriou
complic
result
fatal
outcom
complic
hepati
dysfunct
occur
patient
perhap
consid
part
spectrum
diseas
rather
complic
abnorm
liver
function
usual
transient
howev
fatal
hepat
necrosi
associ
infecti
mononucleosi
report
cn
involv
occur
patient
may
caus
death
neurolog
abnorm
includ
meningoenceph
polyradiculopathi
transvers
myeliti
syndrom
unilater
facial
palsi
ophthalm
defect
expand
occipit
mass
two
lifethreaten
complic
secondari
sever
lymphoid
tissu
hyperplasia
acut
airway
obstruct
requir
intub
tracheostomi
splenic
ruptur
spleen
tens
swollen
thin
splenic
capsul
trabecula
normal
abnorm
lymphocyt
infiltr
around
intratubular
arteri
intima
vein
blood
sinus
common
benign
complic
includ
maculopapular
prurit
rash
occur
mani
patient
mononucleosi
given
ampicillin
rash
also
occur
signific
number
patient
given
penicillin
complic
treatment
associ
streptococc
pharyng
unusu
complic
includ
hemolyticurem
syndrom
orchiti
pneumon
mediastin
mass
rey
syndrom
electrocardiograph
abnorm
proteinlos
enteropathi
multiorgan
involv
infecti
mononucleosi
demonstr
autopsi
materi
patient
die
traumat
recov
diseas
week
earlier
monocellular
infiltr
found
liver
kidney
heart
lung
brain
adren
test
overal
mortal
rate
infecti
mononucleosi
probabl
less
per
case
diagnosi
diagnosi
base
clinic
manifest
laboratori
test
peripher
blood
count
reveal
lymphocytosi
least
cell
socau
downey
ceil
atyp
lymphocyt
cell
larger
normal
lymphocyt
abnorm
shape
nuclei
dens
chromatin
network
vacuol
foami
cytoplasm
total
leukocyt
count
normal
low
first
week
increas
cell
per
cumm
second
week
hepat
dysfunct
elev
serum
glutam
oxaloacet
transaminas
sgot
serum
glutam
pyruv
transaminas
sgpt
lactic
acid
dehydrogenas
ldh
also
consid
diagnost
criterion
heterophil
agglutin
test
paul
bunneu
demonstr
high
titer
agglutinin
sheep
erythrocyt
sera
patient
infecti
mononucleosi
heterophil
antibodi
low
titer
also
found
patient
serum
sick
normal
person
forssman
antibodi
therefor
differenti
adsorpt
test
introduc
davidsohn
test
test
base
observ
heterophil
agglutinin
produc
infecti
mononucleosi
adsorb
beef
erythrocyt
guinea
pig
kidney
cell
revers
true
forssmantyp
normal
occur
heterophil
agglutinin
serum
sick
antibodi
remov
guinea
pig
kidney
cell
beef
erythrocyt
fourfold
differ
guinea
pig
kidney
beef
erythrocyt
titer
consid
signific
diagnos
infecti
mononucleosi
adsorpt
pattern
present
tabl
heterophil
antibodi
usuauy
appear
end
ofth
first
week
although
may
disappear
end
second
week
may
persist
week
longer
consequ
neg
test
repeat
long
enough
onset
ill
permit
serolog
convers
spot
test
recent
year
sever
slide
test
develop
monospot
among
wide
use
differenti
test
adsorpt
guinea
pig
kidney
beef
erythrocyt
perform
slide
hors
erythrocyt
instead
sheep
red
cell
test
posit
stronger
earlier
agglutin
seen
adsorpt
guinea
pig
kidney
cell
adsorpt
beef
erythroeyt
monospot
reliabl
rapid
requir
small
amount
capillari
blood
patient
fals
neg
result
extrem
rare
fals
posit
reaction
infrequ
usual
transient
report
occasion
rubella
viral
hepat
cmv
infect
leukemia
adenoviru
infect
pancreat
carcinoma
two
instanc
patient
slide
test
reliabl
substitut
heterophil
antibodi
test
eb
virusspecif
serodiagnost
testmthes
test
prefer
nonspecif
test
indic
younger
children
may
present
unusu
clinic
pictur
patient
persist
neg
heterophil
antibodi
titer
adult
popul
higher
percentag
children
diagnosi
suspect
clinic
basi
antibodi
eb
viru
sera
patient
infecti
mononucleosi
describ
henl
et
al
antibodi
found
sera
children
burkitt
lymphoma
soon
becam
evid
eb
viru
antibodi
could
found
mani
clinic
condit
hodgkin
lymphoma
nasopharyng
carcinoma
well
normal
popul
latter
percentag
vari
accord
age
socioeconom
statu
popul
studi
recent
year
sever
technic
measur
antibodi
differ
antigen
eb
viru
develop
eb
virusspecif
igm
antibodi
appear
incub
period
rise
high
titer
acut
phase
detect
convalesc
test
detect
primari
infect
therefor
help
diagnos
current
infecti
mononucleosi
gener
use
tripl
layer
immunofluoresc
technic
schmitz
et
al
promis
test
done
easili
rapidli
antibodi
diffus
compon
earli
antigen
detect
acut
phase
serum
patient
infecti
mononucleosi
titer
declin
disappear
convalesc
phase
igg
antibodi
measur
indirect
immunofluoresc
technic
henl
et
al
antibodi
eb
viru
capsid
antigen
measur
use
indirect
immunofluoresc
technic
histor
antibodi
first
detect
infecti
mononucleosi
henl
et
al
titer
begin
rise
earli
acut
phase
declin
later
remain
detect
sever
year
probabl
life
wide
use
test
epidemiolog
survey
infecti
mononucleosi
neutral
antibodi
hewer
et
al
titer
also
rise
acut
phase
persist
mani
year
test
complic
perform
laboratori
complement
fix
antibodi
solubl
antigen
vonka
et
al
antibodi
eb
virusassoci
nuclear
antigen
appear
convalesc
phase
remain
elev
sever
year
test
use
determin
immun
infecti
mononucleosi
yet
perform
routin
therapi
therapi
case
infecti
mononucleosi
support
analges
relief
pain
salin
wash
sore
throat
help
pharyng
caus
group
streptococcu
pyogen
occur
frequent
infecti
mononucleosi
therefor
patient
unusu
toxic
throat
cultur
done
posit
appropri
antibiot
therapi
indic
use
steroid
treatment
infecti
mononucleosi
controversi
bolden
et
al
doubleblind
studi
shown
cours
prednison
hasten
return
normal
temperatur
differenti
leukocyt
count
heterophil
antibodi
titer
believ
steroid
reserv
seriou
complic
upper
airway
obstruct
cn
involv
hematolog
abnorm
eg
thrombocytopenia
hemolyt
anemia
upper
airway
obstruct
improv
occur
promptli
endotrach
intub
tracheostomi
avoid
recommend
prednison
full
dose
ainvay
obstruct
reliev
dosag
may
rapidli
taper
discontinu
acut
viral
hepat
system
infecti
diseas
affect
liver
predominantli
term
includ
two
clinic
similar
form
hepat
hepat
b
previous
use
name
infecti
hepat
serum
longer
accur
form
diseas
transmit
either
oral
parenter
rout
synonym
hepat
includ
infecti
hepat
short
incub
hepat
hepat
catarrh
hepat
hepat
b
also
known
serum
hepat
longincub
hepat
australia
antigen
hepat
hepat
studi
human
volunt
shown
least
two
virus
hepat
viru
b
caus
viral
hepat
although
attempt
cultur
hepat
b
virus
tissu
transmit
anim
fail
exhibit
sever
viral
characterist
pass
bacteriaretain
filter
resist
freez
long
period
time
destroy
heat
c
minut
also
resist
chlorin
ether
hepat
b
antigen
blumberg
associ
discov
antigen
serum
australian
aborigin
react
sera
multipli
transfus
hemophil
patient
antigen
origin
call
australia
au
antigen
subsequ
studi
identifi
antigen
sera
patient
ill
hepat
b
hepat
henc
altern
design
au
antigen
includ
hepatitisassoci
antigen
serum
hepat
antigen
current
prefer
hepat
b
surfac
antigen
hbag
three
differ
particl
identifi
electron
microscopi
liver
specimen
taken
patient
acut
hepat
dane
particl
nm
diamet
long
tubular
form
nm
diamet
small
sphere
nm
diamet
dane
particl
may
turn
hepat
b
viru
particl
consist
core
outer
surfac
compon
specif
antigen
properti
surfac
compon
antigen
similar
nm
particl
thu
accord
current
nomenclatur
hb
ag
hepat
b
antigen
found
sttrlace
dane
particl
unattach
nm
particl
hepat
b
antigen
found
within
core
dane
particl
denot
hbcag
hbag
found
sera
patient
hepat
b
also
demonstr
nuclei
cytoplasm
liver
cell
patient
hepat
b
antigen
usual
detect
serum
week
month
evid
abnorm
sgot
activ
durat
hbag
blood
variabl
usual
disappear
within
sever
week
month
occasion
persist
year
chronic
carrier
hbsag
may
complet
asymptomat
normal
abnorm
liver
function
test
mother
acut
hepat
b
seem
infecti
transmit
hbag
babi
mother
asymptomari
chronic
carrier
case
howev
persist
antigenemia
abnorm
liver
function
test
found
babi
epidemiolog
studi
suggest
tendenc
persist
hbag
inherit
autosom
recess
genet
factor
hbag
found
sera
normal
popul
europ
unit
state
higher
incid
hbag
demonstr
sera
resid
tropic
countri
patient
syndrom
hodgkin
diseas
lepromat
leprosi
leukemia
needleus
drug
addict
patient
treat
chronic
hemodialysi
epidemiolog
hepat
common
children
young
adult
hepat
b
show
age
prefer
hepat
b
worldwid
distribut
common
mode
transmiss
hepat
fecalor
rout
primarili
persontoperson
contact
commonsourc
outbreak
due
contamin
water
milk
uncook
seafood
associ
hepat
hepat
b
often
transmit
parenter
although
may
spread
fecalor
rout
outbreak
hepat
b
common
hepat
except
patient
personnel
hemodialysi
center
among
parenter
drug
abus
transfus
whole
blood
serum
plasma
use
infect
needl
syring
tattoo
instrument
may
sourc
hepat
b
well
hepat
risk
clinic
appar
hepat
follow
transfus
case
per
transfus
patient
risk
anicter
hepat
follow
transfus
may
time
greater
exposur
asymptomat
carrier
hbag
person
undiagnos
anicteri
hepat
also
repres
signific
sourc
infect
patholog
patholog
chang
acut
viral
hepat
b
indistinguish
light
microscopi
caus
swell
necrosi
liver
ceil
mononuclear
cell
infiltr
portal
zone
studi
electron
microscopi
shown
intranuclear
cytoplasm
viruslik
particl
patient
hbsagposit
hepat
viral
hepat
also
lead
massiv
necrosi
liver
acut
yellow
atrophi
liver
cell
complet
destroy
evid
regener
clinic
manifest
sever
vari
asymptomat
carrier
stale
hbag
fulmin
hepat
necrosi
death
instanc
hepat
selflimit
diseas
case
fatal
rate
low
recoveri
rule
children
anicteri
form
common
diseas
gener
less
sever
adult
ratio
icter
anicter
hepat
estim
children
adult
viru
b
usual
caus
sever
hepat
viru
incub
period
day
hepat
day
hepat
b
viru
found
blood
week
onset
jaundic
hepat
hbsag
may
found
earli
month
prior
onset
jaundic
hepat
b
hepat
viru
excret
fece
last
week
ill
although
oral
transmiss
occur
hepat
b
period
viru
excret
fece
known
preicter
phase
two
day
day
onset
jaundic
symptom
malais
fatigu
develop
anorexia
particular
distast
coffe
cigarett
occur
patient
may
complain
epigastri
right
upper
quadrant
pain
onset
fever
f
flulik
symptom
coryza
cough
myalgia
common
hepat
usual
begin
abruptli
hepat
b
insidi
onset
high
fever
uncommon
darkcolor
urin
lightcolor
fece
note
day
onset
jaundic
serum
sicknesslik
pictur
urticaria
skin
rash
polyarthr
seen
patient
hepat
b
less
frequent
hepat
symptom
may
due
immunocomplex
diseas
caus
hbsag
icter
phase
prodrom
symptom
fever
gastrointestin
discomfort
subsid
jaundic
appear
appetit
usual
return
patient
asymptomat
jaundic
sever
pruritu
common
adult
rare
children
liver
usual
palpabl
tender
splenomegali
posterior
cervic
lymphadenopathi
found
patient
icteri
phase
averag
durat
day
children
week
adult
convalesc
phase
convalesc
usual
rapid
unev
children
adult
fatigu
may
promin
last
sever
week
longer
laboratori
find
presenc
hbsag
hepat
b
laboratori
distinct
hepat
preicteri
phase
usual
leukopenia
toward
end
phase
atyp
lymphocyt
appear
sustain
leukocytosi
evid
viral
hepat
prodrom
phase
progress
elev
sgot
sgpt
level
sgpt
usual
higher
sgot
peak
sgpt
level
unit
characterist
transaminas
level
may
return
normal
week
sometim
persist
sever
month
clinic
jaundic
detect
serum
bilirubin
usual
mg
may
reach
mg
serum
alkalin
phosphatas
slightli
elev
bodanski
unit
thymol
turbid
increas
sever
day
sgot
return
normal
later
elev
igg
igm
may
occur
acut
phase
serolog
fino
antibodi
hbsag
antihb
found
popul
test
washington
c
area
malefemal
ratio
equal
unexplain
high
frequenc
antihb
group
absenc
antibodi
age
group
antihb
igg
igm
class
neither
consist
detect
earli
show
definit
pattern
transmiss
persist
antihb
found
multipli
transfus
patient
commerci
blood
donor
detect
patient
infect
hepat
patient
antihb
develop
prior
appear
clinic
hepat
hb
ag
may
anamnesti
respons
previou
subclin
exposur
hb
ag
although
may
correl
earli
antibodi
respons
resist
overt
ill
exposur
antibodi
hbag
may
impli
immun
reinfect
may
due
differ
subtyp
viru
antihb
may
neutral
infecti
vidon
core
dna
polymeras
associ
core
dane
particl
correl
period
peak
hepat
b
viru
replic
antibodi
core
antigen
antihbc
detect
sera
blood
donor
implic
case
posttransfus
reaction
detect
hbag
antihb
antihb
also
found
hbagneg
blood
donor
hbagposit
blood
donor
chronic
hbag
carder
may
sensit
indic
viral
replic
assay
hbag
antihb
antihbc
dna
polymeras
may
give
complet
inform
screen
blood
product
diagnos
hepat
b
immun
immun
serum
globulin
given
prior
earli
exposur
viral
hepat
prevent
clinic
manifest
diseas
although
enzymat
chang
still
occur
immun
globulin
high
titer
antihb
appear
protect
viral
hepat
type
b
transmit
nonparenter
earli
studi
fail
show
efficaci
immun
serum
globulin
preor
postop
prevent
posttransfus
hepat
katz
shown
decreas
posttransfus
hepat
modifi
gamma
globulin
ad
blood
prior
transfus
krugman
use
heatinactiv
sera
contain
prototyp
hepat
b
viru
strain
activ
immun
children
challeng
viru
infecti
form
demonstr
prior
immun
lead
attenu
infect
decreas
chronic
carrier
state
hb
ag
block
appear
hbag
dna
polymeras
antihbc
work
may
lead
develop
attenu
viral
vaccin
treatment
specif
treatment
infecti
hepat
requir
bed
rest
necessari
acut
stage
diseas
previous
healthi
militari
recruit
prolong
ill
effect
increas
relaps
rate
embark
earli
exercis
program
follow
infecti
hepat
balanc
diet
offer
patient
appetit
return
corticosteroid
therapi
indic
uncompl
case
may
lead
increas
relaps
rate
chronic
diseas
complic
peptic
ulcer
pyogen
infect
fulmin
hepat
liver
failur
may
complic
cours
appropri
therapi
carri
includ
protein
restrict
steril
gut
provis
adequ
calori
carbohydr
establish
caus
effect
relationship
certain
virus
certain
diseas
ideal
method
make
etiolog
diagnosi
torecov
viru
site
patholog
recoveri
viru
concomit
serolog
convers
sourc
site
patholog
proof
infect
necessarili
proof
viru
relat
diseas
question
addit
serolog
studi
expens
time
consum
herrmann
clearli
correctli
state
case
practic
feasibl
specif
viral
diagnosi
clearli
document
problem
impract
diagnost
approach
classic
virologist
word
serolog
studi
best
presumpt
necess
retrospect
therefor
littl
valu
manag
patient
use
sever
differ
cell
cultur
permit
recoveri
virus
caus
infect
children
suffici
frequenc
rapid
affect
patient
care
one
take
account
sourc
specimen
suspect
diagnosi
age
patient
season
time
requir
produc
cytopatholog
cytopatholog
chang
produc
cell
cultur
viru
recogn
high
degre
accuraci
specif
serotyp
enteroviru
isol
specimen
csf
gener
import
hand
recoveri
enteroviru
csf
often
report
littl
hour
usual
within
hour
inform
extrem
help
care
patient
even
though
epidemiolog
studi
show
infect
children
caus
virus
antibiot
use
treat
mani
patient
antibiot
valu
treatment
viral
infect
evid
suggest
antibiot
prescrib
viral
infect
decreas
incid
secondari
bacteri
infect
promiscu
use
antibiot
add
alreadi
burdensom
cost
medic
care
may
caus
untoward
reaction
rang
mild
gastrointestin
disturb
sever
toxic
manifest
deaf
renal
hepatocellular
damag
bone
marrow
suppress
fatal
aplast
anemia
fatal
anaphylaxi
antibiot
also
produc
mark
chang
normal
flora
predispos
patient
develop
secondari
infect
invari
difficult
treat
practic
physician
often
find
horn
dilemma
lay
public
expect
inde
often
demand
antibiot
almost
ill
infecti
physician
often
hesit
withhold
antibiot
face
possibl
bacteri
infect
may
believ
erron
antibiot
good
sure
harm
may
also
think
specif
etiolog
diagnosi
unnecessari
one
antibiot
prescrib
provid
broad
coverag
probabl
etiolog
agent
except
lifethreaten
infect
use
antibiot
often
avoid
care
evalu
patient
period
sever
hour
along
select
laboratori
studi
case
bacteri
infect
progress
associ
increas
toxic
hand
viral
infect
tend
reach
plateau
period
sever
day
neither
progress
improv
experi
suggest
assum
attitud
antibiot
prescrib
without
reason
indic
lifethreaten
infect
strong
evid
bacteri
etiolog
antibiot
usag
greatli
reduc
without
signific
threat
patient
goal
practic
physician
strive
